For many years, KMD Bioscience has been dedicated to antibody development research, equipped with an experienced technical team, well-established and robust process systems, and comprehensive antibody preparation facilities. We offer recombinant monoclonal antibody preparation services derived from multiple species, including mouse, rabbit, alpaca, sheep, and chicken.
The mouse remains the most widely used and classical immunized host in the field of monoclonal antibody generation. Mice exhibit rapid reproductive rates, small body sizes, short immunization and development cycles, and their husbandry conditions are readily standardized. Moreover, commonly used inbred mouse strains, validated through decades of scientific research and industrial applications, possess highly homogeneous and stable genetic backgrounds, with well‑characterized and reproducible immune response profiles. Monoclonal antibodies generated from the murine system are characterized by strong antigen recognition specificity, minimal batch‑to‑batch variability, and low non‑specific background reactivity.
Compared with conventional methodologies, the single B-cell antibody technology offers distinct advantages, including accelerated timelines, high throughput, and exceptional specificity. This approach involves the isolation of antigen‑specific single B lymphocytes, followed by direct PCR amplification of the antibody variable-region coding genes. Subsequent core steps include sequence determination, construction of recombinant expression vectors, expression verification at the cellular level, and antibody purification. Leveraging this technology platform, KMD Bioscience provides clients with a comprehensive, end‑to‑end service for murine monoclonal antibody preparation, enabling the delivery of mouse-derived recombinant monoclonal antibodies with both high antigen specificity and high binding affinity within a short turnaround time.
0
